The prognosis for perihilar cholangiocarcinoma is generally poor due to late diagnosis and the aggressive nature of the disease. The 5-year survival rate for localized, resectable tumors can be up to 30-40%, but it drops significantly for advanced stages. Early detection and advances in treatment are crucial for improving outcomes.
